Labetalol HCL

Product NDC
71335-2063
11-digit product format
713352063
Labeler code
71335
Product ID
71335-2063_5b73d168-447e-407c-b98f-8347b6cfd9e7
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Labetalol Hydrochloride
Dosage form
TABLET, FILM COATED
Route
ORAL
Labeler
Bryant Ranch Prepack
Application
ANDA200908
Marketing category
ANDA
Marketing start
2012-07-24
Substance
LABETALOL HYDROCHLORIDE
Active strength
200 mg/1
Pharmacologic classes
Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Additional Listing Data#

Finished product
Yes
Brand name base
Labetalol HCL
Listing expiration
2026-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
LABETALOL HYDROCHLORIDE200 mg/1

Harmonized Identifiers#

Field, Values table
FieldValues
Unii1GEV3BAW9J
Rxcui896762

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionMarketing startMarketing endSampleExclude flagStatus
71335-2063-17133520630130 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (71335-2063-1) 2022-03-160000-00-00NoNoCurrent
71335-2063-27133520630290 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (71335-2063-2) 2024-10-070000-00-00NoNoCurrent
71335-2063-37133520630360 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (71335-2063-3) 2022-05-060000-00-00NoNoCurrent